These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27161901)

  • 1. Weight change in the management of youth-onset type 2 diabetes: the TODAY clinical trial experience.
    Marcus MD; Wilfley DE; El Ghormli L; Zeitler P; Linder B; Hirst K; Ievers-Landis CE; van Buren DJ; Walders-Abramson N;
    Pediatr Obes; 2017 Aug; 12(4):337-345. PubMed ID: 27161901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY.
    TODAY Study Group
    Diabetes Care; 2013 Jun; 36(6):1749-57. PubMed ID: 23704674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consumption of Beverages Containing Low-Calorie Sweeteners, Diet, and Cardiometabolic Health in Youth With Type 2 Diabetes.
    Sylvetsky AC; Chandran A; Talegawkar SA; Welsh JA; Drews K; El Ghormli L
    J Acad Nutr Diet; 2020 Aug; 120(8):1348-1358.e6. PubMed ID: 32711855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical trial to maintain glycemic control in youth with type 2 diabetes.
    ; Zeitler P; Hirst K; Pyle L; Linder B; Copeland K; Arslanian S; Cuttler L; Nathan DM; Tollefsen S; Wilfley D; Kaufman F
    N Engl J Med; 2012 Jun; 366(24):2247-56. PubMed ID: 22540912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Youth-onset type 2 diabetes mellitus: lessons learned from the TODAY study.
    Narasimhan S; Weinstock RS
    Mayo Clin Proc; 2014 Jun; 89(6):806-16. PubMed ID: 24702733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes.
    ; Zeitler P; Epstein L; Grey M; Hirst K; Kaufman F; Tamborlane W; Wilfley D
    Pediatr Diabetes; 2007 Apr; 8(2):74-87. PubMed ID: 17448130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
    Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
    J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of the treatment of youth-onset type 2 diabetes: the TODAY experience.
    TODAY Study Group
    Diabetes Care; 2013 Jun; 36(6):1765-71. PubMed ID: 23704676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Surgical and Medical Therapy for Type 2 Diabetes in Severely Obese Adolescents.
    Inge TH; Laffel LM; Jenkins TM; Marcus MD; Leibel NI; Brandt ML; Haymond M; Urbina EM; Dolan LM; Zeitler PS;
    JAMA Pediatr; 2018 May; 172(5):452-460. PubMed ID: 29532078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postintervention Effects of Varying Treatment Arms on Glycemic Failure and β-Cell Function in the TODAY Trial.
    TODAY Study Group
    Diabetes Care; 2021 Jan; 44(1):75-80. PubMed ID: 33290248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment on: TODAY Study Group. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY. Diabetes Care 2013;36:1749-1757.
    Baldi JC; Manning PJ; Hofman PL; Walker RJ
    Diabetes Care; 2013 Dec; 36(12):e223. PubMed ID: 24265392
    [No Abstract]   [Full Text] [Related]  

  • 12. Design of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study.
    TODAY Study Group
    Int J Obes (Lond); 2010 Feb; 34(2):217-26. PubMed ID: 19823189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.
    Viberti G; Kahn SE; Greene DA; Herman WH; Zinman B; Holman RR; Haffner SM; Levy D; Lachin JM; Berry RA; Heise MA; Jones NP; Freed MI
    Diabetes Care; 2002 Oct; 25(10):1737-43. PubMed ID: 12351470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presentation and effectiveness of early treatment of type 2 diabetes in youth: lessons from the TODAY study.
    Kelsey MM; Geffner ME; Guandalini C; Pyle L; Tamborlane WV; Zeitler PS; White NH;
    Pediatr Diabetes; 2016 May; 17(3):212-21. PubMed ID: 25690268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Biomarkers in Youth with Type 2 Diabetes Mellitus: Results from the TODAY Study.
    Gidding SS; Bacha F; Bjornstad P; Levitt Katz LE; Levitsky LL; Lynch J; Tryggestad JB; Weinstock RS; El Ghormli L; Lima JAC;
    J Pediatr; 2018 Jan; 192():86-92.e5. PubMed ID: 29246363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment effects on measures of body composition in the TODAY clinical trial.
    TODAY Study Group
    Diabetes Care; 2013 Jun; 36(6):1742-8. PubMed ID: 23704673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to a lifestyle program for youth with type 2 diabetes and its association with treatment outcome in the TODAY clinical trial.
    Berkowitz RI; Marcus MD; Anderson BJ; Delahanty L; Grover N; Kriska A; Laffel L; Syme A; Venditti E; Van Buren DJ; Wilfley DE; Yasuda P; Hirst K;
    Pediatr Diabetes; 2018 Mar; 19(2):191-198. PubMed ID: 28664624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A primary care register for impaired glucose handling (IGH): impact on cardiometabolic profile.
    Heald AH; Knapman H; Nair S; Chambers T; Radford D; Rushton T; Anderson SG
    Prim Care Diabetes; 2012 Oct; 6(3):213-9. PubMed ID: 22560663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of metformin monotherapy and dual therapy with sodium glucose co-transporter 2 inhibitor (SGLT-2) in treatment of type 2 diabetes mellitus.
    Molugulu N; Yee LS; Ye YT; Khee TC; Nie LZ; Yee NJ; Yee TK; Liang TC; Kesharwani P
    Diabetes Res Clin Pract; 2017 Oct; 132():157-168. PubMed ID: 28797524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin monotherapy for type 2 diabetes mellitus.
    Saenz A; Fernandez-Esteban I; Mataix A; Ausejo M; Roque M; Moher D
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002966. PubMed ID: 16034881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.